InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.06
(
-0.09%
)
Bitcoin
66,534.13
(
-0.16%
)
Post# of 2341350
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HiddenGem69

Send PM Follow Ignore
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

HiddenGem69

Re: HiddenGem69 post# 1212869

Monday, 09/30/2013 9:41:55 AM

Monday, September 30, 2013 9:41:55 AM

Post# of 2341350
$NVLX The approval of the combination for first-line use means that it is now the treatment of choice for the disease. Oddly, this news may account for the late day rally last Friday in Nuvilex, Inc.'s (OTCQB: NVLX) shares as they very well could be next in line to approach the FDA with even better data than Celgene.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up